Showing results (101-110 of 664) with videos related to
Sort By:
Pageof 67
Circulatory Shock|January 1, 1986
Mediation of flow-dependent arterial dilation by endothelial cellsL Kaiser, H V SparksJournal of Clinical Microbiology|May 1, 1996
Comparative susceptibilities of human embryonic fibroblasts and HeLa cells for isolation of human rhinovirusesE Arruda, C E Crump, B S Rollins, et al.The Journal of Infectious Diseases|November 1, 1991
Virulence of rimantadine-resistant human influenza A (H3N2) viruses in ferretsC Sweet, F G Hayden, K J Jakeman, et al.The Journal of Infectious Diseases|September 1, 1990
Peripheral blood mononuclear cell interleukin-2 and interferon-gamma production, cytotoxicity, and antigen-stimulated blastogenesis during experimental rhinovirus infectionJ Hsia, A L Goldstein, G L Simon, et al.The Journal of Infectious Diseases|December 12, 1997
Effects of the neuraminidase inhibitor zanamavir on otologic manifestations of experimental human influenzaJ B Walker, E K Hussey, J J Treanor, et al.The Journal of Infectious Diseases|July 1, 1987
Human nasal mucosal responses to topically applied recombinant leukocyte A interferonF G Hayden, B Winther, G R Donowitz, et al.The Journal of Allergy and Clinical Immunology|April 1, 1996
Oral prednisone therapy in experimental rhinovirus infectionsL M Gustafson, D Proud, J O Hendley, et al.Journal of Clinical Microbiology|January 1, 1997
Epidemiologic evidence for Lancefield group C beta-hemolytic streptococci as a cause of exudative pharyngitis in college studentsJ C Turner, F G Hayden, M C Lobo, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 17, 1998
Safety of influenza vaccine in heart transplant recipientsE A Blumberg, J Fitzpatrick, P C Stutman, et al.Antimicrobial Agents and Chemotherapy|July 2, 1999
Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infectionD P Calfee, A W Peng, L M Cass, et al.Pageof 67